PatientsVille.com LogoPatientsVille.com

Acne Lesions | Acne Detection Software (AcneDect)

Acne Lesions research study

What is the primary objective of this study?

This study is to create a self-learning software that can detect acne lesions. Patients take a picture of their face every single day for 3 months with a secure mobile phone and fill out a pre-designed questionnaire. After 3 months, the mobile will be collected back and the pictures will be evaluated by 3 dermatologists. The software is able to learn from the dermatologists' evaluation and -using machine learning- a mechanism that should be able to automatically detect acne to some extent will be established.

Who is eligible to participate?

Inclusion Criteria: - Acne vulgaris Exclusion Criteria: - Refusal to participate

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Acne Lesions

Acne Vulgaris

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Other:Self- learning software that can detect acne lesionsSelf- learning software that can detect acne lesions from patients who take a picture of their face every single day for 3 months with a secure mobile phone.

Other:Patient reported outcomesCollection of patient reported outcomes and clinical data via a mobile electronic case report form

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Study Status

Not yet recruiting

Start Date: September 2019

Completed Date: October 2020

Phase:

Type: Observational

Design:

Primary Outcome: Collection of pictures to train the AcneDect software

Secondary Outcome: AcneDect questionnaire regarding acne burden (VAS scale ranging from "Not bad at all" to "Very bad")

Study sponsors, principal investigator, and references

Principal Investigator: Alexander A. Navarini, Prof. Dr. MD

Lead Sponsor: University Hospital, Basel, Switzerland

Collaborator:

More information:https://clinicaltrials.gov/show/NCT04060160

Discuss